Sei Investments Co. Lowers Position in Balchem Co. (NASDAQ:BCPC)

Sei Investments Co. reduced its stake in shares of Balchem Co. (NASDAQ:BCPC - Free Report) by 1.6% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 107,424 shares of the basic materials company's stock after selling 1,757 shares during the period. Sei Investments Co. owned approximately 0.33% of Balchem worth $17,510,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Pathstone Holdings LLC lifted its stake in Balchem by 6.5% during the third quarter. Pathstone Holdings LLC now owns 10,361 shares of the basic materials company's stock worth $1,824,000 after purchasing an additional 632 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. bought a new stake in Balchem in the 3rd quarter worth approximately $1,153,000. Charles Schwab Investment Management Inc. boosted its stake in Balchem by 2.1% in the third quarter. Charles Schwab Investment Management Inc. now owns 361,970 shares of the basic materials company's stock worth $63,707,000 after buying an additional 7,562 shares in the last quarter. Citigroup Inc. grew its position in Balchem by 61.1% during the third quarter. Citigroup Inc. now owns 43,178 shares of the basic materials company's stock valued at $7,599,000 after acquiring an additional 16,378 shares during the last quarter. Finally, Bank of Montreal Can raised its stake in shares of Balchem by 1.6% during the third quarter. Bank of Montreal Can now owns 28,488 shares of the basic materials company's stock worth $4,989,000 after acquiring an additional 456 shares in the last quarter. 87.91% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on BCPC. HC Wainwright reaffirmed a "buy" rating and issued a $190.00 price objective on shares of Balchem in a research note on Monday, February 24th. Sidoti upgraded shares of Balchem to a "hold" rating in a research report on Tuesday, February 25th. Finally, StockNews.com cut Balchem from a "buy" rating to a "hold" rating in a research note on Tuesday, February 25th.

Balchem Trading Up 0.7 %

Shares of NASDAQ:BCPC traded up $1.24 during trading on Tuesday, reaching $167.24. 183,240 shares of the company traded hands, compared to its average volume of 123,147. The firm has a market capitalization of $5.44 billion, a price-to-earnings ratio of 42.55, a P/E/G ratio of 4.41 and a beta of 0.63. Balchem Co. has a 52-week low of $137.69 and a 52-week high of $186.03. The company has a current ratio of 1.99, a quick ratio of 1.16 and a debt-to-equity ratio of 0.19. The business's fifty day moving average is $165.46 and its 200-day moving average is $169.23.

Balchem (NASDAQ:BCPC - Get Free Report) last posted its quarterly earnings results on Friday, February 21st. The basic materials company reported $1.03 EPS for the quarter, missing analysts' consensus estimates of $1.11 by ($0.08). Balchem had a net margin of 13.47% and a return on equity of 11.37%. The firm had revenue of $240.00 million for the quarter, compared to the consensus estimate of $239.96 million. As a group, analysts forecast that Balchem Co. will post 4.64 EPS for the current year.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.